Eight Technological "Must Haves" To Support Your Decentralized Clinical Trial
Source: Remarque Systems
Over the past decade, there has been a gradual uptick in the popularity of decentralized clinical trials (DCTs)—a trend that has accelerated dramatically due to Covid-19. Now, there will be no going back, largely for patients. “Patient-centricity” is more than an industry buzzword; it is a form of enlightened self-interest for sponsors and researchers. By minimizing the burden of participating in a clinical trial, sponsors simplify recruitment and increase retention and compliance. Study effectiveness is amplified and drugs get to market faster, saving patient lives and sponsor money.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more